Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Immunol ; 71(10): 992-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20650301

ABSTRACT

Although genetic variants in tumor necrosis factor (TNF), mannose binding lectin (MBL), and the vitamin D receptor (VDR) have been associated with leprosy clinical outcomes, these findings have not been extensively validated. We used a case-control study design with 933 patients in Nepal, which included 240 patients with type I reversal reaction (RR), and 124 patients with erythema nodosum leprosum (ENL) reactions. We compared genotype frequencies in 933 cases and 101 controls of seven polymorphisms, including a promoter region variant in TNF (G -308A), three polymorphisms in MBL (C154T, G161A and G170A), and three variants in VDR (FokI, BsmI, and TaqI). We observed an association between TNF -308A and protection from leprosy with an odds ratio of 0.52 (95% confidence interval = 0.29-0.95, p = 0.016). MBL polymorphism G161A was associated with protection from lepromatous leprosy (odds ratio = 0.33, 95% confidence interval = 0.12-0.85, p = 0.010). VDR polymorphisms were not associated with leprosy phenotypes. These results confirm previous findings of an association of TNF -308A with protection from leprosy and MBL polymorphisms with protection from lepromatous leprosy. The statistical significance was modest and will require further study for conclusive validation.


Subject(s)
Leprosy/genetics , Leprosy/immunology , Mannose-Binding Lectin/genetics , Receptors, Calcitriol/genetics , Tumor Necrosis Factor-alpha/genetics , Adult , DNA Mutational Analysis , Erythema Nodosum , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Leprosy/physiopathology , Male , Nepal , Polymorphism, Genetic , Promoter Regions, Genetic/genetics
2.
Clin Sci (Lond) ; 114(5): 347-60, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18230059

ABSTRACT

Although several lines of evidence suggest that variation in human inflammation is genetically controlled, the genes which regulate these responses are largely unknown. TLRs (Toll-like receptors) mediate recognition of microbes, regulate activation of the innate immune response and influence the formation of adaptive immunity. Cellular and molecular studies over the past several years have identified a number of common TLR polymorphisms that modify the cellular immune response and production of cytokines in vitro. In addition, human genetic studies suggest that some of these polymorphisms are associated with susceptibility to a spectrum of diseases. In this review, we summarize studies of common TLR polymorphisms and how this work is beginning to illuminate the influence of human variation on inflammation and disease susceptibility.


Subject(s)
Genetic Predisposition to Disease , Polymorphism, Genetic , Toll-Like Receptors/genetics , Humans , Immunity, Innate/genetics , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/immunology , Opportunistic Infections/genetics , Signal Transduction/immunology , Toll-Like Receptors/immunology
3.
Eur J Immunol ; 37(8): 2280-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17595679

ABSTRACT

Toll-like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses through TLR1/2 or TLR2/6 heterodimers. It is not currently known whether polymorphisms in TLR1 regulate the innate immune response. We stimulated human whole blood with triacylated lipopeptide, a ligand for TLR1/2 heterodimers, and found substantial inter-individual variation in the immune response. We sequenced the coding region of TLR1 and found a non-synonymous polymorphism, I602S (base pair T1805G), that regulated signalling. In comparison to TLR1_602S, the 602I variant mediated substantially greater basal and lipopeptide-induced NF-kappaB signalling in transfected HEK293 cells. These signalling differences among TLR1 variants were also found with stimulation by extracts of Mycobacterium tuberculosis. Furthermore, individuals with the 602II genotype produced substantially more IL-6 than those with the 602SS variant in a lipopeptide-stimulated whole-blood cytokine assay. Together, these observations demonstrate that variation in the inflammatory response to bacterial lipopeptides is regulated by a common TLR1 transmembrane domain polymorphism that could potentially impact the innate immune response and clinical susceptibility to a wide spectrum of pathogens.


Subject(s)
Bacterial Proteins/immunology , Immunity, Innate , Lipoproteins/immunology , Toll-Like Receptor 1/genetics , Base Sequence , Fluorescent Antibody Technique , Humans , Immunoblotting , Mycobacterium tuberculosis/immunology , NF-kappa B , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...